Mission Statement

Juan Carlos Perez Lozada, MD, is an interventional radiologist who says he enjoys the minimally invasive aspect of his work that allows patients to recover rapidly.“The extensive variety of pathology each day makes this field my passion,” Dr. Perez Lozada says. “My favorite part of interventional radiology is the scope and breadth of clinical conditions and procedures that I can treat and the constant innovation of my field. I love that I still am able to guide and counsel patients in clinic and be part of their treatment team.” He says he always lets his patients know that their well-being is his priority. “I want them to be safe regardless of the procedure. I want the best treatment possible regardless of the specialty that will take care of them,” he says. “The best patient is the one that has knowledge of their options.” Dr. Perez Lozada offers uterine fibroid embolization, spine interventions, pain management and nerve blocks, dialysis interventions, management of deep venous thrombosis and pulmonary embolism, and interventional oncology.

Dr. Hyder is Professor of Radiology & Biomedical Imaging and Professor of Biomedical Engineering, where he is a founding faculty member. He is Head of MRS Group of the MRRC and Director of QNMR Research Program. He studied physical chemistry at Wabash College (BA 1990) and biophysical chemistry at Yale University (PhD 1995). Dr. Hyder studies brain energy metabolism. His lab develops magnetic resonance (MR) based imaging methods to study brain physiology and chemistry, revealing how neuronal-glial cells fuel their function and (re)growth. He posits that mapping metabolic dysfunction (e.g., energetics for cellular function vs. cellular proliferation) can indicate early biomarkers of brain disorders and diseases. To map brain’s physiology and chemistry with MR-based imaging and spectroscopic advances and targeted delivery and monitoring of treatments, his laboratory conducts multidisciplinary functional and molecular imaging of neurodegeneration and neuro-oncology, requiring expertise in physics to chemistry to engineering to cancer biology to neuroscience. His contributions include development of high-resolution fMRI in preclinical models, calibrated fMRI for quantitative imaging of neuronal activity, and molecular imaging methods for pH and temperature mapping and other physiological parameters that are relevant in cancer diagnosis and treatment. Dr. Hyder has written and edited books on functional brain imaging and holds several patents on molecular imaging of cancer. His research work has produced over 240 papers with as many invited presentations, amassing over 20K citations. He has had continuous NIH support for 25 years, spanning across interests from 7 different NIH institutes. He has renewed grants from different funding agencies and has received several early career awards from. He sits on editorial boards of several scientific journals, and he reviews for many scientific journals spanning several disciplines. He serves on advisory panels of several funding agencies. Dr. Hyder holds many honors, including the Melvin H. Knisely Award from the International Society on Oxygen Transport to Tissue, the Niels Lassen Award from the International Society for Cerebral Blood Flow and Metabolism, and the Lundbeck Foundation Visiting Professorship at the University of Copenhagen. He has fellowships in American Institute for Medical and Biological Engineering, Academy of Radiology & Biomedical Imaging Research, and Sigma Xi the Scientific Research Honor Society. Recently, he was appointed Head of Trumbull College at Yale University and received a General Assembly Official Citation from the State of Connecticut.

Dr. Graeme F. Mason develops experimental models and methods for studies of brain metabolism using 1H and 13C Nuclear Magnetic Resonance (NMR) and Mass Spectrometry in conjunction with 13C isotopic labeling in vivo, in cell preparations, and other systems. His work began during his graduate studies at Yale where he used a rat model for the experimental determination of brain glucose transport kinetics, energetics, and neurotransmitter metabolism. Dr. Mason received further training at the University of Alabama at Birmingham, where he guided the group's 13C-labeling studies of the human brain in vivo in the 4.1T whole-body MR system. Dr. Mason studies metabolism and neurotransmission in the brain in vivo, including effects of psychiatric, neurological, and metabolic conditions. Dr. Mason examines healthy subjects and patients to investigate relationships among GABA, glutamate, and glutamine concentrations and their rates of synthesis and release in the brain, in particular with regard to effects of acute and chronic use of alcohol. He also studies detailed kinetic modeling of isotopomer and isotopologues using data from high-resolution NMR and mass spectrometry.

Ayah Megahed is a PGY4, ESIR (Chief) resident at Yale New Haven Health, Bridgeport Hospital. She earned her medical degree and completed a Radiology Residency at Ain Shams University, in Cairo, Egypt before joining her current residency program.  She is highly passionate about Interventional Radiology, education and global outreach.

Martin is an Integrated Interventional Radiology resident at the Yale-New Haven Hospital. He has a particular interest in oncology and global outreach, an interest inspired by the vast opportunities for change in cancer management he identified while growing up in Kenya as well as while conducting cancer research and providing direct/indirect care to patients with cancer at various institutions in the USA. He attended Rice University for college after which he worked as a cancer researcher at the University of Chicago for two years. He received his medical training at Northwestern Feinberg School of Medicine and completed an internship in General Surgery at the Mount Sinai Medical Center in Miami Beach.

Dr. Rothman is director of the Magnetic Resonance Research Center (MRRC) at the Yale School of Medicine. The MRRC presently supports the NIH- funded work of more than 70 Principal Investigators, as well as 13 program project grants and center grants. Dr. Rothman has an international reputation as a leader in the development of novel MR methods for the study of brain, liver, and muscle metabolism and function. Among the many MR 'firsts' of his team of bioimaging scientists have been the development of MR methods for imaging glutamate and GABA neurotransmission, brain energy metabolism, and liver and muscle glycogen and glucose metabolism and metabolic control. He is presently supported by two R01 grants, and has served as the primary mentor of six postdoctoral fellows and two students. His postdoctoral fellows have all gone on to faculty positions at major research institutions in the US and abroad. He is a named mentor on five K awards at different levels and is an informal mentor to many other junior and mid-level faculty members in the use of MR technology in their research.

I am a musculoskeletal and diagnostic radiologist at Yale. I am both fellowship trained in musculoskeletal and body MR imaging at NYU Langone Medical Center. I am well versed in diagnostic and interventional musculoskeletal procedures inclusive of fluoroscopic, CT and ultrasound guided interventional procedures. I have a strong interest in teaching medical students, residents and fellows. I have been actively participating in multidisciplinary conferences. I have interest in and published articles related to engaging shoulder dislocations and pediatric development patterns of the shoulder and ankle/foot.